BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36652189)

  • 1. The Impact of Receipt of Information on Prostate-Specific Antigen Testing on Screening with the Prostate-Specific Antigen Test.
    McCormick ME; Haile ZT
    J Cancer Educ; 2023 Aug; 38(4):1313-1321. PubMed ID: 36652189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparities Associated with Shared Decision-making in Prostate Cancer Screening.
    Basin MF; Crane K; Basnet A; Chandrasekar T; Shapiro O; Jacob JM; Bratslavsky G; Goldberg H
    Eur Urol Focus; 2023 Nov; 9(6):1008-1015. PubMed ID: 37198068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The State of Prescreening Discussions About Prostate-specific Antigen Testing Following Implementation of the 2012 United States Preventive Services Task Force Statement.
    Turini GA; Gjelsvik A; Renzulli JF
    Urology; 2017 Jun; 104():122-130. PubMed ID: 28322897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Patterns in Shared Decision Making for Prostate-Specific Antigen Testing in the United States.
    Fedewa SA; Gansler T; Smith R; Sauer AG; Wender R; Brawley OW; Jemal A
    Ann Fam Med; 2018 Mar; 16(2):139-144. PubMed ID: 29531105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening.
    Li J; Zhao G; Hall IJ
    Am J Prev Med; 2015 Aug; 49(2):259-63. PubMed ID: 25997905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National evidence on the use of shared decision making in prostate-specific antigen screening.
    Han PK; Kobrin S; Breen N; Joseph DA; Li J; Frosch DL; Klabunde CN
    Ann Fam Med; 2013; 11(4):306-14. PubMed ID: 23835816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Shared decision making in prostate-specific antigen testing with men older than 70 years.
    Li J; Berkowitz Z; Richards TB; Richardson LC
    J Am Board Fam Med; 2013; 26(4):401-8. PubMed ID: 23833155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-Specific Antigen Testing Initiation and Shared Decision-Making: Findings from the 2000 and 2015 National Health Interview Surveys.
    Li J; Ding H; Richards TB; Martin I; Kobrin S; Marcus PM
    J Am Board Fam Med; 2018; 31(4):658-662. PubMed ID: 29986994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Men Receive Information Required for Shared Decision Making About PSA Testing? Results from a National Survey.
    Leyva B; Persoskie A; Ottenbacher A; Hamilton JG; Allen JD; Kobrin SC; Taplin SH
    J Cancer Educ; 2016 Dec; 31(4):693-701. PubMed ID: 26498649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National trends in prostate cancer screening among older American men with limited 9-year life expectancies: evidence of an increased need for shared decision making.
    Drazer MW; Prasad SM; Huo D; Schonberg MA; Dale W; Szmulewitz RZ; Eggener SE
    Cancer; 2014 May; 120(10):1491-8. PubMed ID: 24523016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Associations of Content and Context of Communication with Prostate-Specific Antigen Testing.
    Alford NA; Wongpaiboon M; Luque JS; Harris CM; Tawk RH
    Int J Environ Res Public Health; 2023 May; 20(9):. PubMed ID: 37174239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of health literacy on shared decision making for prostate-specific antigen screening in the United States.
    Nguyen DD; Trinh QD; Cole AP; Kilbridge KL; Mahal BA; Hayn M; Hansen M; Han PKJ; Sammon JD
    Cancer; 2021 Jan; 127(2):249-256. PubMed ID: 33165954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shared decision making and prostate-specific antigen based prostate cancer screening following the 2018 update of USPSTF screening guideline.
    Jiang C; Fedewa SA; Wen Y; Jemal A; Han X
    Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):77-80. PubMed ID: 32296126
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician Consultations, Prostate Cancer Knowledge, and PSA Screening of African American Men in the Era of Shared Decision-Making.
    Woods-Burnham L; Stiel L; Wilson C; Montgomery S; Durán AM; Ruckle HR; Thompson RA; De León M; Casiano CA
    Am J Mens Health; 2018 Jul; 12(4):751-759. PubMed ID: 29658371
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shared decision making in prostate-specific antigen testing: the effect of a mailed patient flyer prior to an annual exam.
    Landrey AR; Matlock DD; Andrews L; Bronsert M; Denberg T
    J Prim Care Community Health; 2013 Jan; 4(1):67-74. PubMed ID: 23799692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostate Cancer Screening Uptake in Transgender Women.
    Kalavacherla S; Riviere P; Kalavacherla S; Anger JT; Murphy JD; Rose BS
    JAMA Netw Open; 2024 Feb; 7(2):e2356088. PubMed ID: 38353948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.
    Carter HB
    BJU Int; 2013 Sep; 112(5):543-7. PubMed ID: 23924423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does shared decision making increase prostate screening uptake in countries with a low prevalence of prostate cancer?
    Amin HS; Arafa MA; Farhat KH; Rabah DM; Altaweel AA; Alhammad AH
    Afr Health Sci; 2020 Dec; 20(4):1870-1874. PubMed ID: 34394251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for prostate cancer with the prostate-specific antigen test: are patients making informed decisions?
    O'Dell KJ; Volk RJ; Cass AR; Spann SJ
    J Fam Pract; 1999 Sep; 48(9):682-8. PubMed ID: 10498074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians.
    Qaseem A; Barry MJ; Denberg TD; Owens DK; Shekelle P;
    Ann Intern Med; 2013 May; 158(10):761-769. PubMed ID: 23567643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.